Tien Liang BioTech Co., Ltd. (TPEX:4127)

Market Cap	1.66B -9.5%
Revenue (ttm)	467.02M +12.6%
Net Income	-3.25M
EPS	-0.07
Shares Out	45.76M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,053
Average Volume	183,539
Open	35.80
Previous Close	36.30
Day's Range	35.75 - 36.15
52-Week Range	29.00 - 42.20
Beta	0.52
RSI	49.72
Earnings Date	Mar 13, 2026

About Tien Liang BioTech

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, lower back pain and sore feet, dizziness and blurred vision, thirst, dry tongue and sore throat, and heel pain, as well as rheumatic pain, joint pain, generalized pain, wind-cold-dampness arthralgia, gout, neuralgia, bedwetting, hemorrhoids, and constipation indications; resolving and cough-relieving powder for colds, coughs, bronchitis, cough suppressants, and expect...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1971
• Employees: 88
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4127

Financial Performance

In 2024, Tien Liang BioTech's revenue was 385.21 million, a decrease of -16.26% compared to the previous year's 459.99 million. Earnings were 11.70 million, a decrease of -34.04%.